Evidence map›Paper›PMID 24273736›Full record

ArticleRedox biology2013

The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV.

Shasha Tao, Rebecca Justiniano, Donna D Zhang, Georg T Wondrak

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 99 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Potential Value of a Combination ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Exploring the Impact ofNutrients · 2023
    Article
  11. Article
  12. Review
  13. Review
  14. Frontiers in pharmacology · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Activated PKB/GSK-3Acta pharmaceutica Sinica. B · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shasha TaoDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, 1703 East Mabel Street, Tucson, AZ 85721, USA.
Rebecca Justiniano
Donna D Zhang
Georg T Wondrak
University of Arizona · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
Training in Environmental Toxicology of Human DiseaseT32ES007091 · NIEHS · UNIVERSITY OF ARIZONA · PI Nathan J Cherrington · 1985 to 2026
$10.7M
The protective role of Nrf2 in arsenic-induced toxicity and carcinogenicityR01ES015010 · NIEHS · UNIVERSITY OF ARIZONA · PI ZHANG, DONNA D · 2006 to 2015
$3.4M
Investigation of an anti-cancer phytochemical targeting Nrf2R01CA154377 · NCI · UNIVERSITY OF ARIZONA · PI ZHANG, DONNA D · 2011 to 2015
$1.5M
Targeting Glycolytic Control of Melanoma Cell SurvivalR01CA122484 · NCI · UNIVERSITY OF ARIZONA · PI WONDRAK, GEORG T · 2007 to 2011
$1.3M
Targeting colorectal carcinogenesis using a cinnamon-derived food factorR21CA166926 · NCI · UNIVERSITY OF ARIZONA · PI WONDRAK, GEORG T, ZHANG, DONNA D · 2013 to 2014
$358k
Testing feasibility of artemisinin-based synthetic-lethal suppression of skin phoR03CA167580 · NCI · UNIVERSITY OF ARIZONA · PI WONDRAK, GEORG T · 2012 to 2013
$152k
NCI NIH HHS P30 CA023074NCI NIH HHS R01 CA122484NCI NIH HHS R01CA122484,NCI NIH HHS R01 CA154377NCI NIH HHS R01CA154377NCI NIH HHS R03 CA167580NCI NIH HHS R03CA167580NCI NIH HHS R21 CA166926NCI NIH HHS R21CA166926NIEHS NIH HHS 2R01ES015010NIEHS NIH HHS P30 ES006694NIEHS NIH HHS R01 ES015010NIEHS NIH HHS T32 ES007091
6 · The paper itself

Abstract

Exposure to solar ultraviolet (UV) radiation is a causative factor in skin photocarcinogenesis and photoaging, and an urgent need exists for improved strategies for skin photoprotection. The redox-sensitive transcription factor Nrf2 (nuclear factor-E2-related factor 2), a master regulator of the cellular antioxidant defense against environmental electrophilic insult, has recently emerged as an important determinant of cutaneous damage from solar UV, and the concept of pharmacological activation of Nrf2 has attracted considerable attention as a novel approach to skin photoprotection. In this study, we examined feasibility of using tanshinones, a novel class of phenanthrenequinone-based cytoprotective Nrf2 inducers derived from the medicinal plant Salvia miltiorrhiza, for protection of cultured human skin cells and reconstructed human skin against solar simulated UV. Using a dual luciferase reporter assay in human Hs27 dermal fibroblasts pronounced transcriptional activation of Nrf2 by four major tanshinones [tanshinone I (T-I), dihydrotanshinone (DHT), tanshinone IIA (T-II-A) and cryptotanshinone (CT)] was detected. In fibroblasts, the more potent tanshinones T-I and DHT caused a significant increase in Nrf2 protein half-life via blockage of ubiquitination, ultimately resulting in upregulated expression of cytoprotective Nrf2 target genes (GCLC, NQO1) with the elevation of cellular glutathione levels. Similar tanshinone-induced changes were also observed in HaCaT keratinocytes. T-I and DHT pretreatment caused significant suppression of skin cell death induced by solar simulated UV and riboflavin-sensitized UVA. Moreover, feasibility of tanshinone-based cutaneous photoprotection was tested employing a human skin reconstruct exposed to solar simulated UV (80 mJ/cm(2) UVB; 1.53 J/cm(2) UVA). The occurrence of markers of epidermal solar insult (cleaved procaspase 3, pycnotic nuclei, eosinophilic cytoplasm, acellular cavities) was significantly attenuated in DHT-treated reconstructs that displayed increased immunohistochemical staining for Nrf2 and γ-GCS together with the elevation of total glutathione levels. Taken together, our data suggest the feasibility of achieving tanshinone-based cutaneous Nrf2-activation and photoprotection.

Indexed as

AbietanesCell LineGene Expression RegulationHumansKeratinocytesNF-E2-Related Factor 2Sunscreening AgentsUbiquitinationUltraviolet RaysAbietanesNFE2L2 protein, humanNF-E2-Related Factor 2Sunscreening AgentstanshinoneCHX, cycloheximideCT, cryptotanshinoneDHT, dihydrotanshinoneDihydrotanshinoneDMEM, Dulbecco's modified Eagle's mediumH&E, hematoxylin and eosinHMOX1, heme oxygenase-1IHC, immunohistochemistryMTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromideNQO1, NAD(P)H quinone oxidoreductase 1Nrf2Nrf2, nuclear factor-E2-related factor 2ROS, reactive oxygen speciesSF, sulforaphaneSkin photoprotectionSLL, solar simulated UV lightSolar simulated ultraviolet lightTanshinone IT-II-A, tanshinone IIAT-I, tanshinone IUVA, ultravioletUVB, ultraviolet Bγ-GCS, gamma-glutamate-cysteine ligase

Identifiers

PMID24273736
PMCPMC3836278
OpenAlexW2054988846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.